Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage.

Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Abstract Text:

Ranganath Muniyappa,Sihoon Lee,Hui Chen,Michael J Quon,Ranganath Muniyappa,Sihoon Lee,Hui Chen,Michael J Quon,

Insulin resistance contributes to the pathophysiology of diabetes and is a hallmark of obesity, metabolic syndrome, and many cardiovascular diseases. Therefore, quantifying insulin sensitivity/resistance in humans and animal models is of great importance for epidemiological studies, clinical and basic science investigations, and eventual use in clinical practice. Direct and indirect methods of varying complexity are currently employed for these purposes. Some methods rely on steady-state analysis of glucose and insulin, whereas others rely on dynamic testing. Each of these methods has distinct advantages and limitations. Thus, optimal choice and employment of a specific method depends on the nature of the studies being performed. Established direct methods for measuring insulin sensitivity in vivo are relatively complex. The hyperinsulinemic euglycemic glucose clamp and the insulin suppression test directly assess insulin-mediated glucose utilization under steady-state conditions that are both labor and time intensive. A slightly less complex indirect method relies on minimal model analysis of a frequently sampled intravenous glucose tolerance test. Finally, simple surrogate indexes for insulin sensitivity/resistance are available (e.g., QUICKI, HOMA, 1/insulin, Matusda index) that are derived from blood insulin and glucose concentrations under fasting conditions (steady state) or after an oral glucose load (dynamic). In particular, the quantitative insulin sensitivity check index (QUICKI) has been validated extensively against the reference standard glucose clamp method. QUICKI is a simple, robust, accurate, reproducible method that appropriately predicts changes in insulin sensitivity after therapeutic interventions as well as the onset of diabetes. In this Frontiers article, we highlight merits, limitations, and appropriate use of current in vivo measures of insulin sensitivity/resistance.

Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Publishing Authors By Initials

R Muniyappa,S Lee,H Chen,MJ Quon,R Muniyappa,S Lee,H Chen,MJ Quon,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: American journal of physiology. Endocrinology and

VOLUME: 294

Page Numbers: E15-26

Journal Abbreviation: Am. J. Physiol. Endocrinol. Me

ISSN: 0193-1849

DAY: 23

MONTH: 10

YEAR: 2007

Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 100901226

Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage.

AFFILIATION: Diabetes Unit, NCCAM, NIH, 9 Memorial Drive, Bldg. 9, Rm. 1N-105 MSC 0920, Bethesda, MD 20892. quonm@nih.gov).

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Am J Physiol Endocrinol Metab

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage Related Publications

• An integrated view of insulin resistance and endothelial dysfunction.
• Combination therapy for treatment or prevention of atherosclerosis.
• Comparison between surrogate indexes of insulin sensitivity and resistance and hyperinsulinemic euglycemic clamp estimates in mice.
• Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage.
• Directly dated starch residues document early formative maize (Zea mays L.) in tropical Ecuador.
• Leptin and cardiovascular disease: response to therapeutic interventions.
• Protein kinase C-zeta phosphorylates insulin receptor substrate-1, -3, and -4 but not -2: isoform specific determinants of specificity in insulin signaling.
• Transoral robotic surgery: radical tonsillectomy.